Real-world treatment patterns and cost per patient achieving treatment targets among tirzepatide and semaglutide initiators in US patients with type 2 diabetes.
Journal: Journal of managed care & specialty pharmacy
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Hoog MM, Vallarino C, Maldonado JM, et al. (2026). "Real-world treatment patterns and cost per patient achieving treatment targets among tirzepatide and semaglutide initiators in US patients with type 2 diabetes.". Journal of managed care & specialty pharmacy. https://doi.org/10.18553/jmcp.2026.32.10.1173